Notoginsenoside Ft1 acts as a TGR5 agonist but FXR antagonist to alleviate high fat diet-induced obesity and insulin resistance in mice
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Notoginsenoside Ft1 acts as a TGR5 agonist but FXR antagonist to alleviate high fat diet-induced obesity and insulin resistance in mice
Authors
Keywords
-
Journal
Acta Pharmaceutica Sinica B
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-03-31
DOI
10.1016/j.apsb.2021.03.038
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Profile of Obesity and Comorbidities in Elderly Patients with Heart Failure
- (2020) Alexandra Dădârlat-Pop et al. Clinical Interventions in Aging
- Hyocholic acid species improve glucose homeostasis through a distinct TGR5 and FXR signaling mechanism
- (2020) Xiaojiao Zheng et al. Cell Metabolism
- Intestinal TGR5 agonism improves hepatic steatosis and insulin sensitivity in Western diet-fed mice
- (2019) Patricia D. Finn et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Ablation of gut microbiota alleviates obesity-induced hepatic steatosis and glucose intolerance by modulating bile acid metabolism in hamsters
- (2019) Lulu Sun et al. Acta Pharmaceutica Sinica B
- Recent Advances in Biotransformation of Saponins
- (2019) He et al. MOLECULES
- Gut microbiota–bile acid–interleukin-22 axis orchestrates polycystic ovary syndrome
- (2019) Xinyu Qi et al. NATURE MEDICINE
- Herbal Medicine of the 21st Century: A Focus on the Chemistry, Pharmacokinetics and Toxicity of Five Widely Advocated Phytotherapies
- (2019) S. Suroowan et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Mechanisms controlling hormone secretion in human gut and its relevance to metabolism
- (2019) Alyce M Martin et al. JOURNAL OF ENDOCRINOLOGY
- Herbal drug discovery for the treatment of nonalcoholic fatty liver disease
- (2019) Tingting Yan et al. Acta Pharmaceutica Sinica B
- TGR5 signalling promotes mitochondrial fission and beige remodelling of white adipose tissue
- (2018) Laura A. Velazquez-Villegas et al. Nature Communications
- Gut microbiota and intestinal FXR mediate the clinical benefits of metformin
- (2018) Lulu Sun et al. NATURE MEDICINE
- Obesity
- (2017) Sharon M. Fruh Journal of the American Association of Nurse Practitioners
- An Intestinal Microbiota–Farnesoid X Receptor Axis Modulates Metabolic Disease
- (2016) Frank J. Gonzalez et al. GASTROENTEROLOGY
- G-protein-coupled bile acid receptor plays a key role in bile acid metabolism and fasting-induced hepatic steatosis in mice
- (2016) Ajay C. Donepudi et al. HEPATOLOGY
- TGR5, Not Only a Metabolic Regulator
- (2016) Cong Guo et al. Frontiers in Physiology
- Novel bile acid therapeutics for the treatment of chronic liver diseases
- (2016) Vinod S. Hegade et al. Therapeutic Advances in Gastroenterology
- The regulation of function, growth and survival of GLP-1-producing L-cells
- (2015) R. E. Kuhre et al. CLINICAL SCIENCE
- Advances in the Science, Treatment, and Prevention of the Disease of Obesity: Reflections From aDiabetes CareEditors’ Expert Forum
- (2015) William T. Cefalu et al. DIABETES CARE
- Generating human intestinal tissues from pluripotent stem cells to study development and disease
- (2015) K. L. Sinagoga et al. EMBO JOURNAL
- Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction
- (2015) Changtao Jiang et al. Nature Communications
- Bile acid nuclear receptor FXR and digestive system diseases
- (2015) Lili Ding et al. Acta Pharmaceutica Sinica B
- The bile acid TGR5 membrane receptor: From basic research to clinical application
- (2014) Henri Duboc et al. DIGESTIVE AND LIVER DISEASE
- GPBAR1/TGR5 Mediates Bile Acid-Induced Cytokine Expression in Murine Kupffer Cells
- (2014) Guiyu Lou et al. PLoS One
- Release of GLP-1 and PYY in response to the activation of G protein-coupled bile acid receptor TGR5 is mediated by Epac/PLC-ε pathway and modulated by endogenous H2S
- (2014) Vanitha Bala et al. Frontiers in Physiology
- Mammalian gut immunity
- (2014) Matam Vijay-Kumar et al. Biomedical Journal
- The bile acid membrane receptor TGR5: a novel pharmacological target in metabolic, inflammatory and neoplastic disorders
- (2013) Vanesa Stepanov et al. JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION
- TGR5: A Novel Target for Weight Maintenance and Glucose Metabolism
- (2011) Xiaosong Chen et al. Experimental Diabetes Research
- The G-Protein-coupled bile acid receptor, Gpbar1 (TGR5), negatively regulates hepatic inflammatory response through antagonizing nuclear factor kappa light-chain enhancer of activated B cells (NF-κB) in mice
- (2011) Yan-Dong Wang et al. HEPATOLOGY
- The bile acid membrane receptor TGR5 as an emerging target in metabolism and inflammation
- (2010) Thijs W.H. Pols et al. JOURNAL OF HEPATOLOGY
- Hydrophobic bile salts inhibit gallbladder smooth muscle function via stimulation of GPBAR1 receptors and activation of KATPchannels
- (2010) Brigitte Lavoie et al. JOURNAL OF PHYSIOLOGY-LONDON
- TGR5-Mediated Bile Acid Sensing Controls Glucose Homeostasis
- (2009) Charles Thomas et al. Cell Metabolism
- Bile Acids and Metabolic Regulation: Mechanisms and clinical responses to bile acid sequestration
- (2009) B. Staels et al. DIABETES CARE
- Discovery of 6α-Ethyl-23(S)-methylcholic Acid (S-EMCA, INT-777) as a Potent and Selective Agonist for the TGR5 Receptor, a Novel Target for Diabesity
- (2009) Roberto Pellicciari et al. JOURNAL OF MEDICINAL CHEMISTRY
- Bile acids: Chemistry, physiology, and pathophysiology
- (2009) Maria J Monte et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Bile Acids Metabonomic Study on the CCl4- and α-Naphthylisothiocyanate-Induced Animal Models: Quantitative Analysis of 22 Bile Acids by Ultraperformance Liquid Chromatography−Mass Spectrometry
- (2008) Li Yang et al. CHEMICAL RESEARCH IN TOXICOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started